Neoadjuvant Treatment in Resectable Pancreatic Cancer: A paradigm shift?
Planet Surgery Podcast por Planet Surgery Podcast
Notas del episodio
In this episode our surgeon guest Dr. Nouredin Messaoudi, HPB Surgeon at the University Hospital of Brussel, Belgium, discusses neoadjuvant treatments that are changing the paradigm in resectable pancreatic cancer with Iris Kyle-Leinhase, Medical Manager of Advanced Surgery Benelux and Germany.
Baxter International GBU-00-210100
Palabras clave
surgerycancerresectablepancreaticcancer